China Animal Husbandry Industry

What China Animal Husbandry Industry does

China Animal Husbandry Industry Co., Ltd. (CAHIC, SSE: 600195) is a Beijing-headquartered state-owned enterprise under China Agricultural Development Group, which is directly supervised by the State Council SASAC. Founded in 1998 and listed on the Shanghai Stock Exchange since January 1999, CAHIC operates three core business divisions: veterinary biological products (CAVac/中牧生物), veterinary pharmaceuticals (中牧化药), and animal nutrition products including compound vitamins and premixes (中牧动物营养, Hualuo/华罗 brand). The company manufactures vaccines for foot-and-mouth disease, highly pathogenic avian influenza, pseudorabies, classical swine fever, and companion animal diseases; produces fermentation-based APIs such as tiamulin, tylvalosin tartrate, florfenicol, and tilmicosin; and operates compound vitamin premix facilities designed by Swiss Bühler. CAHIC operates 22 production bases across China and serves large-scale livestock farms and agricultural enterprises through a sales-led model with dedicated division-level sales teams, distribution via wholly-owned and joint-venture subsidiaries, and engagement at major industry conferences.

The company derives revenue from one-time sales of veterinary biological products and pharmaceuticals, plus feed and feed additives under the Hualuo brand and a raw material trading business covering imported and domestic amino acids, fish meal, whey powder, and corn by-products sourced globally. CAHIC is a designated production enterprise for HPAI and FMD vaccines, providing a government procurement-backed revenue stream alongside commercial B2B sales. Manufacturing heritage spans over 90 years (origins in 1931) with the Lanzhou Biological Pharmaceutical Factory founded in 1934, supporting capabilities in veterinary biologics and fermentation-based APIs. The company holds a national enterprise technology center, Beijing municipal engineering research center, Ministry of Agriculture and Rural Affairs key laboratory, and post-doctoral research station, and has received multiple National Science and Technology Progress Awards (2001, 2004, 2006, 2021). Pricing is not publicly disclosed and is negotiated case-by-case with enterprise customers, and CAHIC markets products domestically and internationally via Belt and Road-aligned channels.

Name

China Animal Husbandry Industry

Legal name

中牧实业股份有限公司

Website

https://cahic.cnadc.com.cn

Company type

Public

Founded year

1998

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

China Animal Husbandry Industry Co., Ltd. (CAHIC, SSE: 600195) is a state-owned enterprise that manufactures veterinary vaccines, pharmaceuticals, and compound vitamin premixes across 22 Chinese production bases, serving large-scale livestock farms, agricultural enterprises, and government procurement programs domestically and through Belt and Road markets.

Ownership category

akta.pro rank

Product category

Veterinary Products / Animal Health

NAICS

Animal Food Manufacturing (31111), Other Animal Food Manufacturing (311119)

SIC

Food And Kindred Products (2000), Wholesale-Farm Product Raw Materials (5150), Wholesale-Chemicals & Allied Products (5160)

akta.pro primary industry

Veterinary Vaccines (Biologics) (HLAMAEAL)

akta.pro secondary industry

Manufacturing, Private Label & Co-Manufacturing for Animal Diets (HLAMAHAO)

Keywords

• Veterinary vaccines
• Animal health products
• Feed additives
• Veterinary pharmaceuticals
• Premix feeds

Headquarters

HQ city

Fengtai

HQ country

China

HQ region

Asia

Offices15 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Veterinary Biological Products (兽用生物制品): CAHIC manufactures and sells veterinary vaccines including foot-and-mouth disease, avian influenza, pseudorabies, and other major animal disease vaccines through its three major biological product bases (Jiangxi, Chengdu, Lanzhou). These are sold to large-scale livestock farms and through distribution networks.
2. Veterinary Pharmaceutical Products (兽药): CAHIC produces and sells veterinary chemical drugs and pharmaceutical preparations including tylosin, florfenicol, tiamulin, and feed additives through subsidiaries such as Nanjing Pharmaceutical, Inner Mongolia Zhongmu, Zhongmu Anda, Chengdu Zhongmu, Zhongmu Quanyao, and Shengli Bio.
3. Feed and Feed Additives (饲料及饲料添加剂): CAHIC produces and sells compound vitamin premixes, premixed feeds, and functional feed additives under the '华罗' brand through its subsidiary Zhongmu (Beijing) Animal Nutrition Technology Co., Ltd. and five modern production facilities. Trade of raw materials including amino acids, fish meal, and corn by-products supplements this business.
4. Raw Material Trading (原料贸易): CAHIC trades feed raw materials including imported and domestic amino acids, imported fish meal, whey powder, chicken meal, meat and bone meal, and corn by-products. Trading partners span North America, South America, Russia, Western Europe, Africa, Brazil, and the Middle East.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Core offering

China Animal Husbandry Industry (CAHIC) manufactures and sells veterinary biological products (vaccines for livestock and poultry), veterinary pharmaceuticals (chemical drugs and APIs), feed and feed additives (compound vitamin premixes, premixed feeds, functional additives), and trades raw materials. The company operates 22 production bases and offers more than 1,000 products serving the animal husbandry industry, with annual revenue above 5 billion yuan.

Product overview

China Animal Husbandry Industry Co., Ltd. (CAHIC/中牧股份) is a comprehensive animal health company with three main product segments: veterinary biological products (中牧生物), veterinary pharmaceutical chemicals (中牧化药), and animal nutrition products (中牧动物营养). The veterinary biological segment includes CAVac branded vaccines covering foot-and-mouth disease, swine pseudorabies, circovirus, swine fever, and companion animal vaccines. The chemical pharmaceutical segment covers APIs (florfenicol, tylvalosin, tilmicosin, mequindox) and formulations. The animal nutrition segment offers 华罗 branded premixes, compound vitamins (华罗多维), and functional feed additives. The company operates 22 manufacturing bases across China with over 90 years of manufacturing history, producing more than 1,000 product varieties and maintaining annual revenues exceeding 5 billion yuan.

Differentiator

Problem solved

Functional benefit

Brands

• 中牧生物: 中牧股份生物制品板块产品品牌，包括猪用疫苗、牛羊用疫苗、宠物用疫苗、诊断试剂等产品系列。
• 中牧化药
• 华罗
• 中牧全药
• 华罗预混料
• 华罗多维

Products and services

• Veterinary biological products (vaccines) Vaccines for livestock and poultry, including nationally designated strains for foot-and-mouth disease and avian influenza, sold to livestock farms, poultry integrators, and government veterinary programs.
• Veterinary pharmaceuticals (chemical drugs and APIs) Chemical veterinary drugs and active pharmaceutical ingredients used for treatment and prevention of livestock and poultry disease, sold via direct sales and distributor network.
• Feed additives (compound vitamins, premixed feeds, functional additives) Compound vitamin premixes, premixed feeds, and functional feed additives formulated to enhance animal nutrition, performance, and health, sold to feed mills, integrators, and farms.
• Raw material trading Trading of feed-grade raw materials and agricultural commodities, complementing the core manufacturing business and serving trading counterparties.

Quantifiable outcome

• Over 50 billion yuan in average annual revenue
• +7 more outcomes

Named customers1 record

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Five partnerships are on record, tiered core and historical.

• Swiss Bühler Group (瑞士布勒集团)coreTechnology or Integration · 1 January 2018CAHIC uses Swiss Bühler Group's production equipment across multiple facilities. Bühler designed, manufactured, and installed production lines for Beijing Hualuo, Changchun Hualuo, and Wuhan Hualuo facilities. Bühler equipment enables CAHIC's industry-leading automation and quality control in feed premix production.
• Japan Zeniyaku Kogyo Co., Ltd. (日本全药工业株式会社)coreStrategic or Co-development Partner · 1 July 2017CAHIC established a joint venture with Japan Zeniyaku Kogyo Co., Ltd. — Zhongmu Quanyao (Nanjing) Animal Pharmaceutical Co., Ltd. (中牧全药(南京)动物药品有限公司). The joint venture leverages CAHIC's production capabilities and Zeniyaku's expertise in manufacturing, R&D management, and market services. It specializes in professional, scaled R&D and domestic advanced intramammary infusion production, emphasizing quality and market-oriented service.
• China Agricultural Development Group (中国农业发展集团有限公司)coreOthers · 1 September 2004CAHIC is a wholly-owned/controlled subsidiary of China Agricultural Development Group (中国农业发展集团有限公司). CNADC is a large-scale comprehensive agricultural central enterprise directly supervised by the State Council SASAC. It provides CAHIC with strategic direction, capital support, and access to state-owned enterprise resources and government relationships.
• Shandong Shengli Co., Ltd. (山东胜利股份有限公司, SZE: 000407)coreStrategic or Co-development Partner · 1 January 2004CAHIC (55%) and Shandong Shengli Co., Ltd. (45%) jointly established Shandong Shengli Bioengineering Co., Ltd. (山东胜利生物工程有限公司). The joint venture has a total investment of over 800 million yuan, covers over 500 mu, and is recognized as a high-tech enterprise by Shandong Province Science and Technology Department. It produces tiamulin, hainanmycin, and monensin, with tiamulin and hainanmycin production and sales ranking first globally.
• Swiss Roche (瑞士罗氏公司)historicalStrategic or Co-development Partner · 1 April 1990In the 1980s, CAHIC's predecessor (中国牧工商联合总公司) established a close business relationship with Swiss Roche, the world's largest vitamin company. Roche donated a complete set of compound vitamin production equipment to CAHIC, which was used to establish the Beijing Hualuo Feed Additive Factory in 1990 in Shunyi, Beijing. This established CAHIC's compound vitamin business that continues today under the 华罗 brand.

Scale indicators10 records

Recent moves8 records

Expansion highlights6 records

Others

• New Hope Liuhe (新希望六和): One of China's largest animal feed producers, also operating integrated livestock and food operations. Comparable in CAHIC's premix/feed and raw material trading segments, though New Hope is primarily a feed company without the biologics and pharmaceutical manufacturing capabilities that define CAHIC's primary business.

Direct peers

• Tecon Biology (天康生物): Chinese animal health and nutrition company producing veterinary vaccines (including FMD) and feed products, with integrated livestock operations. Comparable as a diversified Chinese animal health and feed company serving the same livestock farming customer base as CAHIC.
• Jinyu Biotechnology (金宇生物技术): One of China's largest veterinary vaccine manufacturers, producing FMD, avian influenza, and other major livestock vaccines. Directly comparable as a Chinese state-affiliated veterinary biologics producer with similar product categories, designated-producer status, and SOE heritage.
• Pulike Biological Engineering (普莱柯生物): Chinese veterinary biologics company producing vaccines for swine, poultry, and companion animals, including FMD, avian influenza, and pseudorabies vaccines. Comparable as a domestic competitor in the Chinese veterinary vaccine market with overlapping product lines and customer base.
• Wuhan Keqian Biology (武汉科前生物): Chinese veterinary vaccine specialist focused on swine and poultry vaccines, particularly pseudorabies and porcine circovirus. Comparable as a domestic Chinese animal biologics company competing directly with CAHIC's swine vaccine portfolio and serving similar large-scale farm customers.
• Ringpu Bio (天津瑞普生物): Chinese animal health company producing veterinary vaccines, pharmaceuticals, and feed additives with a diversified product portfolio. Comparable as a multi-segment Chinese animal health competitor with overlapping vaccines, veterinary APIs, and nutrition offerings similar to CAHIC's three-pillar structure.

Regional players

• Hester Biosciences: India-based animal health company manufacturing vaccines and health products for poultry, livestock, and companion animals. Comparable as a regionally focused animal biologics player in an emerging market with similar vaccine manufacturing capabilities but operating in a different geography than CAHIC.

Broad incumbents

• Zoetis Inc. Global #1 animal health company offering vaccines, parasiticides, diagnostics, and pharmaceuticals across livestock and companion animals. Comparable as the dominant incumbent in the global animal health space that CAHIC directly competes with in vaccines and APIs, but with a much larger portfolio and R&D budget.
• Boehringer Ingelheim Animal Health: Major global animal health business within Boehringer Ingelheim offering vaccines and pharmaceuticals for livestock and pets. Comparable as a large incumbent competitor in Chinese and emerging markets with overlapping FMD, avian influenza, and swine vaccine products.
• Elanco Animal Health: Global animal health company offering companion animal and livestock vaccines, parasiticides, and feed additives. Comparable as a broad incumbent competing in the Chinese animal health market with overlapping pharmaceutical and vaccine products targeting the same livestock producers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks2 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries16 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about China Animal Husbandry Industry